Insurers rush to get nod for benefit-based health policies

Life insurers given time till October 18 to withdraw existing indemnity plans; Irdai had banned these products

Image via Shutterstock
<a href="http://www.shutterstock.com/pic-245887939.html" target="_blank">Image</a> via Shutterstock
M Saraswathy
Last Updated : Oct 11 2016 | 11:17 PM IST
Life insurance companies are filing new benefit-based health insurance plans with the regulator as they have been barred from selling indemnity plans. The Insurance Regulatory and Development Authority of India (Irdai) has given time till October 18 for these products to be withdrawn from the market.

This means there will be an immediate dearth of such products in the market. Indemnity plans constitute 90-95 per cent of the health portfolio of life insurers and refer to those policies where customers can claim a reimbursement after visiting a doctor or incurring medical expenses.

According to regulatory officials, life insurers are in the midst of withdrawing existing plans and getting new products approved.

“We are lining up multiple products and riders with Irdai so that we have at least a few health plans on offer when the existing ones are withdrawn,” said the head of products at a mid-size life insurance company.

According to information from the Life Insurance Council, there are 12 health products in-force. Over and above, there are about 45 riders that are in-force in the life insurance segment. Of these, the majority are indemnity products, which will have to be withdrawn.

While several products are still awaiting approval, companies started launching benefit-based products.

For instance, Exide Life Insurance has launched Exide Life Sanjeevani, which is a fixed benefit health plan. This offers comprehensive coverage against all prevalent heart and cancer-related conditions.

In its health insurance regulations in July 2016, Irdai had said a life insurer could not offer indemnity-based products in individual or group segments.

Insurers will have to give a prospective date of closure for indemnity-based products not later than three months from the date of notification of the regulation. For existing policyholders, the policy shall continue until the expiry of the term.

Further, Irdai said no single premium health insurance product could be offered under the unit-linked platform.

Earlier, life insurers used to offer mediclaim policies, while non-life and stand-alone health insurers offered specialised policies.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Oct 11 2016 | 11:14 PM IST

Next Story